News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Milan District Court Confirms The Validity Of Alfa Wasserman's Rifaximin-Alpha Patents


6/12/2014 8:12:40 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOLOGNA, Italy, June 12, 2014 /PRNewswire via COMTEX/ -- BOLOGNA, Italy, June 12, 2014 /PRNewswire/ --

Normix® is the only authorized Gastrointestinal antibiotic based on Rifaximin-alpha. No generic version is allowed.

With the judgment entered last April 18, the district court of Milan, Italy - the court having origi nal jurisdiction on the matter - denied a request from generic manufacturers to declare Alfa Wassermann ' s patents on R ifaximin polymorphs invalid.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES